Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bariatric Surgery | 12 | 2023 | 194 | 2.210 |
Why?
|
| Obesity, Morbid | 11 | 2023 | 225 | 2.010 |
Why?
|
| Pandemics | 4 | 2020 | 740 | 1.110 |
Why?
|
| Surgery Department, Hospital | 3 | 2020 | 42 | 1.040 |
Why?
|
| Laparoscopy | 9 | 2020 | 754 | 0.960 |
Why?
|
| Esophagectomy | 3 | 2017 | 84 | 0.900 |
Why?
|
| Infection Control | 3 | 2020 | 115 | 0.880 |
Why?
|
| Perioperative Care | 4 | 2019 | 161 | 0.880 |
Why?
|
| Patient Selection | 4 | 2020 | 685 | 0.800 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 316 | 0.760 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 301 | 0.760 |
Why?
|
| Postoperative Complications | 9 | 2023 | 2207 | 0.740 |
Why?
|
| Stomach Neoplasms | 7 | 2020 | 266 | 0.710 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 57 | 0.700 |
Why?
|
| Health Resources | 1 | 2020 | 76 | 0.700 |
Why?
|
| Weight Loss | 7 | 2023 | 229 | 0.700 |
Why?
|
| Gastric Bypass | 6 | 2017 | 110 | 0.660 |
Why?
|
| Decision Making | 2 | 2020 | 642 | 0.620 |
Why?
|
| Gastrectomy | 4 | 2013 | 68 | 0.610 |
Why?
|
| Smoke | 1 | 2017 | 27 | 0.600 |
Why?
|
| Health Communication | 1 | 2017 | 13 | 0.590 |
Why?
|
| Carbon Monoxide | 1 | 2017 | 90 | 0.580 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2008 | 153 | 0.570 |
Why?
|
| Clinical Protocols | 1 | 2017 | 156 | 0.570 |
Why?
|
| Triage | 3 | 2020 | 108 | 0.530 |
Why?
|
| Length of Stay | 2 | 2017 | 700 | 0.490 |
Why?
|
| Esophageal Neoplasms | 3 | 2020 | 321 | 0.490 |
Why?
|
| Obesity | 4 | 2017 | 963 | 0.490 |
Why?
|
| Metabolic Diseases | 2 | 2015 | 48 | 0.480 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2014 | 30 | 0.480 |
Why?
|
| Malabsorption Syndromes | 2 | 2009 | 21 | 0.450 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 237 | 0.420 |
Why?
|
| Quality Improvement | 3 | 2023 | 428 | 0.420 |
Why?
|
| Pneumonectomy | 1 | 2014 | 196 | 0.410 |
Why?
|
| Robotics | 1 | 2014 | 267 | 0.380 |
Why?
|
| Humans | 48 | 2023 | 86601 | 0.380 |
Why?
|
| Surgical Stapling | 1 | 2010 | 17 | 0.380 |
Why?
|
| Gastroplasty | 1 | 2010 | 21 | 0.370 |
Why?
|
| Fundoplication | 1 | 2010 | 72 | 0.360 |
Why?
|
| Hospitals | 2 | 2023 | 294 | 0.340 |
Why?
|
| Lung Diseases | 1 | 2011 | 263 | 0.340 |
Why?
|
| Hospital Mortality | 1 | 2011 | 348 | 0.340 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 117 | 0.330 |
Why?
|
| Betacoronavirus | 3 | 2020 | 258 | 0.330 |
Why?
|
| Stomach | 1 | 2008 | 108 | 0.320 |
Why?
|
| Foreign Bodies | 1 | 2008 | 63 | 0.320 |
Why?
|
| Biliopancreatic Diversion | 1 | 2006 | 4 | 0.290 |
Why?
|
| Anticoagulants | 3 | 2020 | 408 | 0.290 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2006 | 8 | 0.290 |
Why?
|
| Surgical Wound Infection | 2 | 2019 | 184 | 0.290 |
Why?
|
| Intestines | 1 | 2009 | 411 | 0.280 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2018 | 120 | 0.280 |
Why?
|
| Retrospective Studies | 13 | 2023 | 8475 | 0.280 |
Why?
|
| Venous Thromboembolism | 2 | 2020 | 153 | 0.270 |
Why?
|
| Internet | 2 | 2020 | 312 | 0.270 |
Why?
|
| Middle Aged | 18 | 2020 | 25017 | 0.250 |
Why?
|
| Adenocarcinoma | 4 | 2020 | 1169 | 0.240 |
Why?
|
| Risk Assessment | 4 | 2020 | 2261 | 0.240 |
Why?
|
| Treatment Outcome | 10 | 2023 | 7988 | 0.220 |
Why?
|
| Male | 21 | 2020 | 40956 | 0.210 |
Why?
|
| Colectomy | 2 | 2020 | 167 | 0.200 |
Why?
|
| Double-Balloon Enteroscopy | 1 | 2021 | 11 | 0.200 |
Why?
|
| Guideline Adherence | 2 | 2020 | 223 | 0.200 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 79 | 0.190 |
Why?
|
| Adult | 16 | 2020 | 25640 | 0.180 |
Why?
|
| Chemoprevention | 1 | 2020 | 91 | 0.180 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 58 | 0.180 |
Why?
|
| Aged | 10 | 2020 | 18402 | 0.180 |
Why?
|
| Patient Care Bundles | 1 | 2019 | 20 | 0.180 |
Why?
|
| Female | 19 | 2020 | 44507 | 0.170 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 116 | 0.170 |
Why?
|
| Operating Rooms | 1 | 2020 | 126 | 0.170 |
Why?
|
| Glucuronosyltransferase | 1 | 2020 | 184 | 0.170 |
Why?
|
| Risk | 1 | 2020 | 674 | 0.160 |
Why?
|
| Venous Thrombosis | 2 | 2014 | 243 | 0.160 |
Why?
|
| Body Mass Index | 3 | 2017 | 770 | 0.160 |
Why?
|
| Thinness | 1 | 2017 | 43 | 0.150 |
Why?
|
| Fires | 1 | 2017 | 17 | 0.150 |
Why?
|
| Enoxaparin | 1 | 2016 | 23 | 0.150 |
Why?
|
| Hemorrhage | 1 | 2018 | 268 | 0.140 |
Why?
|
| Mentors | 1 | 2017 | 76 | 0.140 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2016 | 70 | 0.140 |
Why?
|
| Logistic Models | 3 | 2019 | 1185 | 0.140 |
Why?
|
| Heparin | 1 | 2016 | 175 | 0.140 |
Why?
|
| Cystectomy | 1 | 2016 | 101 | 0.140 |
Why?
|
| Thrombosis | 1 | 2018 | 296 | 0.130 |
Why?
|
| Chicago | 1 | 2020 | 1379 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1801 | 0.130 |
Why?
|
| Diaphragm | 1 | 2014 | 50 | 0.130 |
Why?
|
| Respiration Disorders | 1 | 2014 | 39 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2016 | 377 | 0.120 |
Why?
|
| Hospitals, Low-Volume | 1 | 2013 | 18 | 0.120 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 303 | 0.120 |
Why?
|
| Smoking | 1 | 2017 | 609 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2014 | 182 | 0.110 |
Why?
|
| Surgeons | 1 | 2017 | 238 | 0.110 |
Why?
|
| Specialties, Surgical | 1 | 2013 | 64 | 0.110 |
Why?
|
| Prognosis | 4 | 2016 | 3674 | 0.110 |
Why?
|
| Illinois | 3 | 2023 | 462 | 0.110 |
Why?
|
| Carcinoma, Lobular | 1 | 2012 | 80 | 0.100 |
Why?
|
| Cadherins | 1 | 2012 | 151 | 0.100 |
Why?
|
| Analysis of Variance | 2 | 2011 | 912 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 1034 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2014 | 839 | 0.100 |
Why?
|
| Patient Care Team | 1 | 2014 | 280 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 731 | 0.100 |
Why?
|
| Surgical Staplers | 1 | 2010 | 11 | 0.090 |
Why?
|
| Diverticulum, Esophageal | 1 | 2010 | 5 | 0.090 |
Why?
|
| Internationality | 3 | 2015 | 69 | 0.090 |
Why?
|
| Adolescent | 4 | 2017 | 8979 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2019 | 4210 | 0.090 |
Why?
|
| Duodenum | 2 | 2007 | 100 | 0.090 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2009 | 6 | 0.090 |
Why?
|
| Vitamin K Deficiency | 1 | 2009 | 5 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 552 | 0.090 |
Why?
|
| Models, Biological | 1 | 2016 | 1749 | 0.090 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6501 | 0.090 |
Why?
|
| Heart Failure | 1 | 2018 | 1203 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2016 | 2767 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 999 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2012 | 535 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 1204 | 0.080 |
Why?
|
| Sex Factors | 1 | 2011 | 1054 | 0.080 |
Why?
|
| Marfan Syndrome | 1 | 2007 | 28 | 0.080 |
Why?
|
| Hernia, Hiatal | 1 | 2007 | 30 | 0.080 |
Why?
|
| Endoscopy, Digestive System | 1 | 2007 | 65 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2011 | 1538 | 0.080 |
Why?
|
| Vitamin D Deficiency | 1 | 2008 | 103 | 0.080 |
Why?
|
| Radiography | 1 | 2008 | 813 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1673 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 1849 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 336 | 0.070 |
Why?
|
| Comorbidity | 1 | 2010 | 943 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 1937 | 0.070 |
Why?
|
| Prosthesis Implantation | 1 | 2007 | 125 | 0.070 |
Why?
|
| Vena Cava Filters | 1 | 2007 | 96 | 0.070 |
Why?
|
| Device Removal | 1 | 2007 | 161 | 0.070 |
Why?
|
| Positron-Emission Tomography | 2 | 2020 | 329 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2007 | 221 | 0.060 |
Why?
|
| Incidence | 2 | 2020 | 1576 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 2270 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2006 | 219 | 0.060 |
Why?
|
| Young Adult | 2 | 2017 | 5974 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 3636 | 0.050 |
Why?
|
| Benchmarking | 1 | 2023 | 78 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2006 | 1565 | 0.050 |
Why?
|
| Mutation | 1 | 2012 | 3967 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2005 | 1078 | 0.050 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 30 | 0.050 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 32 | 0.050 |
Why?
|
| Leucovorin | 1 | 2020 | 218 | 0.040 |
Why?
|
| Intestine, Small | 1 | 2021 | 303 | 0.040 |
Why?
|
| Inpatients | 2 | 2016 | 297 | 0.040 |
Why?
|
| Child | 2 | 2020 | 6926 | 0.040 |
Why?
|
| Postoperative Care | 2 | 2013 | 221 | 0.040 |
Why?
|
| Cross Infection | 1 | 2020 | 141 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2021 | 229 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 2887 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2020 | 556 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2000 | 502 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 388 | 0.040 |
Why?
|
| Risk Factors | 3 | 2017 | 5416 | 0.040 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 15 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2017 | 62 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 121 | 0.030 |
Why?
|
| Overweight | 1 | 2017 | 118 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2000 | 673 | 0.030 |
Why?
|
| Sweden | 1 | 2015 | 40 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 174 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 459 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 297 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2016 | 157 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 1850 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1621 | 0.030 |
Why?
|
| Preoperative Care | 2 | 2008 | 394 | 0.030 |
Why?
|
| Robotic Surgical Procedures | 1 | 2020 | 267 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2000 | 1208 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 812 | 0.030 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2012 | 23 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2012 | 66 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2012 | 285 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2000 | 1565 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 481 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2015 | 572 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2013 | 213 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2000 | 1920 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2014 | 2600 | 0.020 |
Why?
|
| Family | 1 | 2012 | 311 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 458 | 0.020 |
Why?
|
| Disease Management | 1 | 2012 | 327 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 1685 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 2436 | 0.020 |
Why?
|
| Pregnancy, High-Risk | 1 | 2009 | 16 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2501 | 0.020 |
Why?
|
| Indiana | 1 | 2008 | 12 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2009 | 293 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 2357 | 0.020 |
Why?
|
| Gastroscopy | 1 | 2007 | 23 | 0.020 |
Why?
|
| United States | 1 | 2020 | 6665 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2009 | 232 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 2007 | 55 | 0.020 |
Why?
|
| Esophagoscopy | 1 | 2007 | 87 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2007 | 278 | 0.020 |
Why?
|
| Posture | 1 | 2006 | 125 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2007 | 150 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2006 | 82 | 0.020 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2006 | 74 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 751 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2006 | 217 | 0.020 |
Why?
|
| Prevalence | 1 | 2008 | 1239 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2006 | 429 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2009 | 2378 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2005 | 225 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2005 | 482 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 2893 | 0.010 |
Why?
|
| Oxygen | 1 | 2006 | 726 | 0.010 |
Why?
|
| Education, Medical, Graduate | 1 | 2005 | 369 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 2000 | 10 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2000 | 19 | 0.010 |
Why?
|
| S Phase | 1 | 2000 | 62 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2005 | 751 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 5209 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2000 | 2818 | 0.010 |
Why?
|
| Animals | 1 | 2000 | 26581 | 0.000 |
Why?
|